共 28 条
- [24] Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study) CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (04) : 668 - 677
- [25] Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study EUROINTERVENTION, 2016, 12 (01) : 30 - 37
- [26] Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR Ill (Oral Rapamycin in ARgentina) study EUROINTERVENTION, 2009, 5 (02) : 255 - 264